Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The immunological Warburg effect: Can a metabolic‐tumor‐stroma score (MeTS) guide cancer immunotherapy?
Peter J. Siska, Katrin Singer, Katja Evert, et al.
Immunological Reviews (2020) Vol. 295, Iss. 1, pp. 187-202
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Turning cold tumors into hot tumors by improving T-cell infiltration
Yuan‐Tong Liu, Zhi‐Jun Sun
Theranostics (2021) Vol. 11, Iss. 11, pp. 5365-5386
Open Access | Times Cited: 531
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Fanglong Wu, Jin Yang, Junjiang Liu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 451
Immunometabolism: From basic mechanisms to translation
Liza Makowski, Mehdi Chaib, Jeffrey C. Rathmell
Immunological Reviews (2020) Vol. 295, Iss. 1, pp. 5-14
Open Access | Times Cited: 287
Lactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects
An‐Na Chen, Yan Luo, Yuhan Yang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 174
The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment
Yanghong Ni, Xiaoting Zhou, Jia Yang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 104
Unraveling tumor microenvironment of small-cell lung cancer: Implications for immunotherapy
Tian Li, Tianyun Qiao
Seminars in Cancer Biology (2022) Vol. 86, pp. 117-125
Closed Access | Times Cited: 89
Lactate, histone lactylation and cancer hallmarks
Xinyu Lv, Yingying Lv, Xiaofeng Dai
Expert Reviews in Molecular Medicine (2023) Vol. 25
Closed Access | Times Cited: 78
Identification of lactylation related model to predict prognostic, tumor infiltrating immunocytes and response of immunotherapy in gastric cancer
Hao Yang, Xiaoming Zou, Shifeng Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 68
Immunologic tumor microenvironment modulators for turning cold tumors hot
Gholamreza Khosravi, Samaneh Mostafavi, Sanaz Bastan, et al.
Cancer Communications (2024) Vol. 44, Iss. 5, pp. 521-553
Open Access | Times Cited: 61
Targeting the Warburg Effect in Cancer: Where Do We Stand?
Ignasi Barba, Laura Carrillo-Bosch, Joan Seoane
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3142-3142
Open Access | Times Cited: 58
Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer
Esther Strating, Mathijs Verhagen, Emerens Wensink, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 44
Histone lactylation bridges metabolic reprogramming and epigenetic rewiring in driving carcinogenesis: Oncometabolite fuels oncogenic transcription
Yu Zhang, Hang Song, Meili Li, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 17
Lactate and lactylation in cancer
Jie Chen, Ziyue Huang, Ya Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Immunological Classification of Tumor Types and Advances in Precision Combination Immunotherapy
Xiufang Ren, Songyi Guo, Xiaojiao Guan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
MCT4 blockade increases the efficacy of immune checkpoint blockade
Nathalie Babl, Sonja-Maria Decking, Florian Voll, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 10, pp. e007349-e007349
Open Access | Times Cited: 27
Histone lactylation regulates cancer progression by reshaping the tumor microenvironment
Junxing Qu, Peizhi Li, Zhiheng Sun
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Immunosurveillance encounters cancer metabolism
Yu‐Ming Chuang, Sheue‐Fen Tzeng, Ping‐Chih Ho, et al.
EMBO Reports (2024) Vol. 25, Iss. 2, pp. 471-488
Open Access | Times Cited: 15
Microglia lactylation in relation to central nervous system diseases
Hui Yang, Nan Mo, Le Tong, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 1, pp. 29-40
Open Access | Times Cited: 10
Current and future therapies for small cell lung carcinoma
Xiaoqian Zhai, Zhengkun Zhang, Yuxin Chen, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Glycometabolic rearrangements--aerobic glycolysis in pancreatic cancer: causes, characteristics and clinical applications
Lidong Cao, Jiacheng Wu, Xianzhi Qu, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 61
Targeting lactate metabolism for cancer immunotherapy - a matter of precision
Christoph Heuser, Kathrin Renner, Marina Kreutz, et al.
Seminars in Cancer Biology (2022) Vol. 88, pp. 32-45
Open Access | Times Cited: 37
Glutamine inhibition combined with CD47 blockade enhances radiotherapy-induced ferroptosis in head and neck squamous cell carcinoma
An Song, Lei Wu, Boxin Zhang, et al.
Cancer Letters (2024) Vol. 588, pp. 216727-216727
Closed Access | Times Cited: 7
Discovering the strength of immunometabolism in cancer therapy: Employing metabolic pathways to enhance immune responses
Huldani Huldani, Jitendra Malviya, Paul Rodrigues, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 6
Kynurenine induces T cell fat catabolism and has limited suppressive effects in vivo
Peter J. Siska, Jing Jiao, Carina Matos, et al.
EBioMedicine (2021) Vol. 74, pp. 103734-103734
Open Access | Times Cited: 40
Current Advances in PD-1/PD-L1 Blockade in Recurrent Epithelial Ovarian Cancer
Yuedi Zhang, Qiulin Cui, Manman Xu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top